The image shows tumor cells infected by the virus, which expresses a fluorescent protein. Over the days (in the image fifth day), the virus multiplies, generating new virions that infect more cancer cells Scientists at the IDIBAPS Biomedical Research Institute and at the Institute for Research in Biomedicine (IRB Barcelona) lead a study in which...
Category: <span>Cancer</span>
Post
Ever wondered why exercise reduces the risk of CANCER? Scientists say active people are better at removing a by-product that fuels tumours
Exercising helps the body get used to the cancer-causing by-product lactate Study finds lactate plays a key role in developing and spreading cancer University of Colorado research paves the way for new cancer treatments It’s long been known that exercising can reduce the risk of cancer. And now scientists believe they have found another reason why...
Post
Potential antitumor therapeutic strategies of human amniotic membrane and amniotic fluid-derived stem cells.
Abstract As stem cells are capable of self-renewal and can generate differentiated progenies for organ development, they are considered as potential source for regenerative medicine and tissue replacement after injury or disease. Along with this capacity, stem cells have the therapeutic potential for treating human diseases including cancers. According to the origins, stem cells are...
Post
Scientists develop new drug delivery method for cancer therapy
Research Associate Xiuling Li (left) and Associate Professor Christoph Rader led the study on the Florida campus of The Scripps Research Institute. (Photo by Junpeng Qi.) Scientists from the Florida campus of The Scripps Research Institute (TSRI) have developed a new drug delivery method that produces strong results in treating cancers in animal models,...
Post
A New Treatment Destroyed Breast Cancer Tumors in 11 Days Without Chemo
Drug Combination A new clinical trial demonstrated positive effects caused by the drug combination lapatinib and trastuzumab against HER2 positive breast cancer in a treatment period of just 11 days. Led by researchers at the Institute of Cancer Research, London, the University of Manchester, and University Hospital of South Manchester, the study comprised 257 women with HER2 positive breast cancer who...
Post
Drug combination delivered by nanoparticles may help in melanoma treatment
Gavin Robertson, professor of pharmacology, pathology, dermatology, and surgery; director of the Penn State Melanoma and Skin Cancer Center and member of Penn State Cancer Institute, works with associates in the Melanoma Center. The first of a new class of medication that delivers a combination of drugs by nanoparticle may keep melanoma from becoming resistant...
Post
‘Google Earth’ for tumours could change cancer diagnostics and drug testing forever
This entry is part 12 of 16 in the series Grand Challenge Think of a tumour like a rapidly growing city within a patient’s body. Doctors can scan the patient to locate the tumour, much like a satellite can scan the earth and map its cities. And scientists can get a sense of the tumour at...
Post
Leukemia drug fends off cancer for a decade, study shows
The cancer drug Gleevec The cancer drug Gleevec appears to keep chronic myeloid leukemia at bay a decade into treatment — with no signs of additional safety risks, a new study finds. Gleevec — known generically as imatinib — was hailed as a “wonder drug” when it was introduced in 2001 for treating chronic myeloid leukemia (CML)....
Post
Castration-resistant Prostate Cancer Cell Growth Impeded by Endostatin
BIRMINGHAM, Ala. – Failure of hormone deprivation therapy, which is used to slow prostate cancer in patients, leads to castration-resistant prostate cancer, a lethal form of advanced disease with limited treatment options. University of Alabama at Birmingham researchers have discovered that endostatin, a naturally occurring protein in humans, can significantly decrease proliferation of castration-resistant prostate...
Post
Scientists stimulate immune system, stop cancer growth
Increasing expression of a chemical cytokine called LIGHT in mice with colon cancer activated the immune system’s natural cancer-killing T-cells and caused primary tumors and metastatic tumors in the liver to shrink. A chemical found in tumors may help stop tumor growth, according to a new study. Researchers at the University of Illinois at Chicago...